Literature DB >> 12774952

Quantitative motor assessment in myotonic dystrophy.

J Mathieu1, H Boivin, C L Richards.   

Abstract

OBJECTIVE: To establish baseline data, using a quantitative motor evaluation protocol, prior to a prospective longitudinal study of the natural history of muscular involvement in myotonic dystrophy (DM). DESIGN/
METHODS: We conducted a cross-sectional study using a protocol consisting of manual muscle testing (MMT), quantitative muscle testing (QMT), and timed functional testing (TFT) on 50 definite DM patients (27 men, 23 women), aged 16 to 67 years. The relationships between MMT, QMT and TFT scores and disease duration were examined using linear regression analysis.
RESULTS: The muscle weakness was symmetric and the neck flexors and the distal muscles of upper and lower extremities were weaker than proximal muscles. Using MMT scores, the average strength decline was 0.95% per year and was similar for men and women. The strength decline was significantly more rapid for distal muscles than for proximal muscles. Quantitative muscle testing scores documented a strength decline per year of disease duration of 1.2-1.6% for the hip flexors and of 2.0-3.0% for the hand grip flexors.
CONCLUSIONS: We observed significant linear relationships between the scores generated by this protocol and disease duration. These data illustrate the distal to proximal progression of muscular involvement in DM, a pattern of progression well-recognized by the clinicians. The follow-up assessment of a large DM cohort in a longitudinal study will establish whether this quantitative protocol provides sensitive measures of the disease progression.

Entities:  

Mesh:

Year:  2003        PMID: 12774952     DOI: 10.1017/s0317167100053397

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

1.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

2.  Myotonic dystrophy: practical issues relating to assessment of strength.

Authors:  R G Whittaker; E Ferenczi; D Hilton-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

3.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

4.  A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Émilie Petitclerc; Marie Kierkegaard; Jean Mathieu; Élise Duchesne; Luc J Hébert
Journal:  J Neurol       Date:  2018-05-21       Impact factor: 4.849

5.  The Change of Grip Strength in a Patient with Congenital Myotonic Dystrophy Over a 4-year Period.

Authors:  Shin Kikuchi; Naoki Kozuka; Eiji Uchida; Takafumi Ninomiya; Haruyuki Tatsumi; Hidekatsu Takeda; Nobutada Tachi
Journal:  J Jpn Phys Ther Assoc       Date:  2008

6.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

7.  Clinical features of spinal and bulbar muscular atrophy.

Authors:  Lindsay E Rhodes; Brandi K Freeman; Sungyoung Auh; Angela D Kokkinis; Alison La Pean; Cheunju Chen; Tanya J Lehky; Joseph A Shrader; Ellen W Levy; Michael Harris-Love; Nicholas A Di Prospero; Kenneth H Fischbeck
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

8.  The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.

Authors:  Luc J Hébert; Jean-François Remec; Joanne Saulnier; Christophe Vial; Jack Puymirat
Journal:  BMC Musculoskelet Disord       Date:  2010-04-18       Impact factor: 2.362

9.  Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.

Authors:  Mark P Jensen; Amy J Hoffman; Brenda L Stoelb; Richard T Abresch; Gregory T Carter; Craig M McDonald
Journal:  Arch Phys Med Rehabil       Date:  2008-02       Impact factor: 3.966

10.  Aceneuramic Acid Extended Release Administration Maintains Upper Limb Muscle Strength in a 48-week Study of Subjects with GNE Myopathy: Results from a Phase 2, Randomized, Controlled Study.

Authors:  Zohar Argov; Yoseph Caraco; Heather Lau; Alan Pestronk; Perry B Shieh; Alison Skrinar; Tony Koutsoukos; Ruhi Ahmed; Julia Martinisi; Emil Kakkis
Journal:  J Neuromuscul Dis       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.